Ayrshire Capital Management’s Gilead Sciences GILD Stock Holding History

Ayrshire Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$690K	Buy	5,462 +62	+1%	+$8.17K	0.32%	39
2026 Q1	$753K	Buy	+5,400	New	+$756K	0.39%	38
2025 Q4	–	Sell	-5,400	Closed	-$599K	–	52
2025 Q3	$599K	Hold	5,400	–	–	0.28%	36
2025 Q2	$599K	Hold	5,400	–	–	0.29%	36
2025 Q1	$605K	Sell	5,400 -15	-0.3%	-$1.55K	0.29%	37
2024 Q4	$500K	Buy	5,415 +15	+0.3%	+$1.35K	0.24%	38
2024 Q3	$453K	Hold	5,400	–	–	0.22%	43
2024 Q2	$370K	Hold	5,400	–	–	0.19%	46
2024 Q1	$396K	Hold	5,400	–	–	0.21%	42
2023 Q4	$437K	Hold	5,400	–	–	0.25%	41
2023 Q3	$405K	Hold	5,400	–	–	0.26%	40
2023 Q2	$414K	Hold	5,400	–	–	0.26%	39
2023 Q1	$448K	Hold	5,400	–	–	0.31%	40
2022 Q4	$464K	Hold	5,400	–	–	0.32%	40
2022 Q3	$333K	Hold	5,400	–	–	0.25%	41
2022 Q2	$334K	Hold	5,400	–	–	0.24%	46
2022 Q1	$321K	Hold	5,400	–	–	0.19%	49
2021 Q4	$392K	Hold	5,400	–	–	0.2%	46
2021 Q3	$377K	Hold	5,400	–	–	0.21%	47
2021 Q2	$372K	Hold	5,400	–	–	0.21%	49
2021 Q1	$349K	Hold	5,400	–	–	0.21%	49
2020 Q4	$315K	Hold	5,400	–	–	0.2%	55
2020 Q3	$341K	Hold	5,400	–	–	0.25%	55
2020 Q2	$415K	Hold	5,400	–	–	0.35%	52
2020 Q1	$404K	Hold	5,400	–	–	0.41%	55
2019 Q4	$351K	Buy	+5,400	New	+$352K	0.29%	60

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ayrshire Capital Management's GILD Position: Q2 2026 in Review

Ayrshire Capital Management increased its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, buying an estimated $8.17K and bringing the position to 5,462 shares worth $690K. The position accounts for 0.32% of the portfolio, ranked #39.

Ayrshire Capital Management first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $753K in Q1 2026. 2,264 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Ayrshire Capital Management held 5,462 shares of Gilead Sciences worth $690K as of Q2 2026.
Ayrshire Capital Management bought 62 Gilead Sciences shares in Q2 2026, an estimated $8.17K.
Gilead Sciences made up 0.32% of Ayrshire Capital Management's portfolio in Q2 2026, its #39 holding.
Ayrshire Capital Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
Ayrshire Capital Management's Gilead Sciences position peaked at $753K in Q1 2026.
2,264 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ayrshire Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.